Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04427020 · ClinicalTrials.gov registry record · NA
Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding
A NA study, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04427020: Completed NA study, sponsored by Lindenwood University.
NCT04427020 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04427020, a NA study, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the pharmacokinetic pattern of amino acid absorption after a two-week pattern of milk protein supplementation with and without the addition of Bacillus coagulans GBI-30, 6086.
Primary Outcome
We intend to determine if the addition of a probiotic to milk protein ingestion changes the rate (in minutes) to which amino acids are absorbed into our bloodstream.
Interventions
- DIETARY_SUPPLEMENT Milk protein + GBI-30
- DIETARY_SUPPLEMENT Milk protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2019-12-03 |
| Phase | NA |
What the finished NCT04427020 record still lists
NCT04427020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Milk protein + GBI-30 is the first listed.
NCT04427020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04427020 about?
NCT04427020 is a clinical study titled "Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding". The purpose of this study is to examine the pharmacokinetic pattern of amino acid absorption after a two-week pattern of milk protein supplementation with and without the addition of Bacillus coagulans GBI-30, 6086.
What is the current status of trial NCT04427020?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-08-08. Estimated completion is 2019-12-03.
What interventions are being tested in trial NCT04427020?
The interventions under investigation include: Milk protein + GBI-30 (DIETARY_SUPPLEMENT), Milk protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04427020?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04427020's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI